Another Xarelto Lawsuit Filed in the Wrongful Death of Tommy Julian
Southfield, MI (Law Firm Newswire) September 23, 2015 – Wrongful death lawsuits arising out of incidents of medical negligence or medical malpractice are often long trials, with the plaintiffs needing financial assistance to pay their bills.
This case is one of many (over 300) enjoined in multi-district litigation (MDL) in the Eastern District of Louisiana.
Tommy Julian began taking Xarelto in November 2012. His personal physician prescribed it to help him reduce his risk of having a stroke. Julian had non-valvular atrial fibrillation, a condition that increased the chances of suffering a stroke.
“In this story, Tommy Julian was taking Xarelto, a drug his son, Danny Julian, says the makers knew had dangerous side effects,” said Daren Monroe, Michigan-based Litigation Funding Corp. representative. Danny Julian filed a wrongful death lawsuit against Johnson & Johnson, Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals, stating that if his father had been informed about the dangerous side effects, he would never had taken it and stood a good chance of still being alive.
The suit seeks punitive and compensatory damages and alleges breach of warranties, fraud, wrongful death, failure to warn, negligent misrepresentation, negligence, negligent design and design defect.
According to the Institute for Safe Medication Practices Quarter Watch, Xarelto had been linked with serious blood clot anomalies, most often pulmonary embolism.
A relatively new drug, only approved by the Food and Drug Administration (FDA) in July 2011, it was touted as having the ability to reduce the risk of blood clots in patients who had hip or knee replacement operations. In November of the same year, the FDA gave it the nod for use with patients with non-valvular atrial fibrillation. It was a once-a-day pill, and supposedly those taking it did not need the same kind of close monitoring as patients on the anticoagulant warfarin.
The elder Julian started taking Xarelto, and several months later suffered from internal bleeding that could not be arrested. He died March 29, 2013. The boxed product contained no warnings about the risk of serious and fatal bleeding, a fact Julien’s attorney would focus on during the eventual trial.
“Apparently the drug maker knew early in their clinical trials that Xarelto caused more stomach bleeding than warfarin and that patients on the drug needed more transfusions than those on warfarin,” said Monroe.
In an emergency, warfarin patients may be given Vitamin K to reverse the effects. There is no antidote in the event of an Xarelto bleed, which causes severe and uncontrollable bleeding.
The younger Julian may be interested in contacting a litigation funding company to inquire about their lawsuit loans. A lawsuit loan, also called pre-settlement funding, is virtually instant cash for a qualified plaintiff with a winnable case. The plaintiff just needs to apply online or call the litigation funding company and discuss his or her case with a representative. The applicant must be working with an attorney and that attorney must be able to provide relevant documentation to the lawsuit loan company.
“It’s a user-friendly system and the lawsuit loan representatives are courteous and extremely experienced in explaining how pre-settlement funding works. While it may not be the ideal solution for everyone, it is worth asking about,” said Monroe.Learn more at http://www.litigationfundingcorp.com